Last mentioned: Feb 25, 2026
FY26 Target
Target date for achieving long-term Adjusted EBITDA margin goals set in the outlook.
Operational Milestone
Expected completion of key back-office automation initiatives to drive margin growth.
Earnings Release
Company reports Q4 results and introduces the FY26 strategic outlook.
Q4 Period End
LifeStance concludes its fiscal fourth quarter with a focus on clinician productivity.
LifeStance Health Group and Dole have released their fourth-quarter results, providing a roadmap for 2026 that highlights divergent paths in the healthcare and consumer staples sectors. While LifeStance focuses on scaling its mental health platform, Dole navigates a complex global supply chain to maintain its fresh produce leadership.
Dole and LifeStance Health Group both released Q4 results and forward-looking FY26 guidance, highlighting a period of stabilization and strategic expansion. While Dole navigates mixed performance in the fresh produce sector, LifeStance continues to scale its mental health footprint, reflecting broader shifts in consumer spending toward essential wellness.
LifeStance Health Group reported its fourth-quarter results for 2025, concurrently issuing a strategic financial outlook for fiscal year 2026. The company is pivoting from aggressive footprint expansion toward margin optimization and clinician retention as it targets long-term profitability.